Ipsen in UK

Ipsen was first established as a UK business in 1981. In the UK Ipsen has a strong presence in research and development, manufacturing and commercial operations. Ipsen has sites in Berkshire, Oxfordshire and North East Wales. These sites span research and development, manufacturing and commercial activities.

 

A biologics centre of excellence, Wrexham is the Ipsen group’s Biologics Development & Manufacturing campus, and is the mainstay of the company’s neurology franchise. The site, in North Wales, is dedicated to the manufacturing and global supply of one of our key products; Dysport. Dysport, a sterile injectable drug that treats several targeted debilitating diseases, is dispensed all around the world in 115 different countries where it makes a meaningful difference to patient’s lives in therapeutic applications. It is marketed as Azzalure in Europe.

The site houses state-of-the-art manufacturing, development and fill-finish facilities, and employs over 350 members of staff.

A strong commitment to research and development can be seen in its Biologics Development activities where a unique team of scientists develop a range of scientifically-advanced, high-quality processes and methodologies required for the manufacture and supply of clinical products across the Ipsen’s Biologics portfolio.

 

Ipsen Limited, Registered in England and Wales under number 6751069
Registered office at 190 Bath Road, Slough, Berkshire, SL1 3XE, UK.
VAT number GB 417 22 9950.

 
Ipsen Wrexham

Date of preparation January 2018 / ALL-UK-000455